Rubio-Guerra AF

Language: Spanish
References: 19
Page: 263-268
PDF size: 126.12 Kb.

Text Extraction

No abstract

REFERENCES

1. Rubio AF. Enfermedad arterial periférica. En: Rubio-Guerra, Castro-Martínez. Controversias en Geriatría. México: Editorial Alfil; 2012, p. 125-32.

2. Cantú-Brito C, Chiquete E, Duarte-Vega M, Rubio-Guerra A, Herrera-Cornejo M, Nettel-García J. Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexicana con riesgo vascular. Rev Med IMSS 2011; 45: 239-46.

3. Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, Gaxiola E, Albuquerque DC, Corbalán R, Ramos A, et al; REACH Latin America Collaborative Group. Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry. Clin Cardiol 2012; 35: 451-7.

4. Aslam F, Haque A, Foody J, Lee V. Peripheral arterial disease: Current Perpectives and new trends in management. South Med J 2009; 102: 1141-9.

5. White C. Intermittent claudication. N Engl J Med 2007; 356: 1241-50.

6. The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J 2011. Doi: 10.1093/eurheartj/ehr211. Advance Access published August 26, 2011.

7. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FG, et al; on behalf of the American Heart Association Council on Peripheral Vascular Disease, Council on Epidemiology and Prevention, Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council. Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement From the American Heart Association. Circulation 2012 [Epub ahead of print]. PMID: 23159553.

8. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295: 547-53.

9. Paravastu SC, Mendonca DA, Da Silva A. Beta blockers for peripheral arterial disease. Eur J Vasc Endovasc Sur 2009; 38: 66-70.

10. The Task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 105-88.

11. Rubio-Guerra AF, Castro-Serna D, Elizalde-Barrera CI, Ramos-Brizuela LM. Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors. Integr Blood Press Control 2009; 2: 55-62.

12. Mediavilla García JD, Fernández-Torres C, Jaén Águila F, Jiménez-Alonso J. Efecto del olmesartán medoxomilo en la rigidez de las grandes arterias en pacientes con hipertensión arterial esencial. Med Clin (Barc) 2007; 128: 726-9.

13. Pale-Torres LJ, Lozano-Nuevo JJ, Rubio-Guerra AF. Índice brazo tobillo y albuminuria en pacientes diabéticos normotensos. Rev Med IMSS 2011; 49: 311-4.

14. Martins D, Pimenta G, Constantino L, Santos T, Rosendo I, Matias C, Miranda P, et al. Ankle-brachial index according to pulse pressure and microalbuminuria in hypertensive patients: a prospective study in family medicine. Rev Port Cardiol 2010; 29: 751-64.

15. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295: 547-53.

16. Hermida RC, Ayala DE, Calvo C, López JE, Fernández JR, Mojón A, Domínguez MJ, et al. Efecto de la administración temporalizada de ácido acetilsalicílico a dosis bajas sobre la presión arterial en pacientes hipertensos. Med Clin (Barc) 2003; 120: 686-92.

17. Preiser JC. Oxidative stress. J Parenter Enteral Nutr 2012; 36: 147-54.

18. Brenner I, Parry M, Brown CA. Exercise interventions for patients with peripheral arterial disease: a review of the literature. Phys Sportsmed 2012; 40: 41-55.

19. National Institute of Health and Clinical excellence. The clinical management of primary hypertension in adults: Clinical guideline 127. NICE. 2011.